Qiryat Shmona, Israel, June 10, 2021: MigVax Ltd., a startup company developing an oral subunit vaccine against COVID-19, today announced promising results from preclinical tests that demonstrated the effectivity of its MigVax-101 subunit oral vaccine as a booster for previously vaccinated persons.
Read more here.
Coinsmart. Beste Bitcoin-Börse in Europa
Source: https://blog.ourcrowd.com/ourcrowd-50-index-fund-is-now-available-on-the-bny-mellon-pershing-alternative-investment-network-2/
